Most blood pressure medications are weight-neutral at best, and some actually cause weight gain. But a few classes of drugs lower blood pressure while also promoting meaningful weight loss, making them especially useful if you’re managing both hypertension and excess weight.
The medications with the strongest evidence for combined blood pressure and weight benefits fall into two main categories: SGLT2 inhibitors and GLP-1 receptor agonists. A specific blood pressure drug called telmisartan also shows unique weight-reducing properties compared to others in its class.
SGLT2 Inhibitors: Blood Pressure and Weight Loss Together
SGLT2 inhibitors work by blocking your kidneys from reabsorbing sugar back into your blood. Instead, excess glucose leaves your body through urine, taking calories with it. This calorie loss drives gradual, sustained weight reduction. The same mechanism creates a mild diuretic effect that helps lower blood pressure independently of the weight loss. In fact, blood pressure drops appear within the first week or two, well before any significant weight change.
The three main SGLT2 inhibitors are empagliflozin, dapagliflozin, and canagliflozin. Clinical trials show weight loss of roughly 2 to 5 kilograms (about 4 to 11 pounds), with the amount varying based on starting weight and other medications you take. The effect builds over time. In studies of canagliflozin, weight dropped about 1.7% at three months and 2.8% at twelve months compared to placebo. Empagliflozin showed significant weight reduction at 12 weeks that continued through one year.
The weight you lose on SGLT2 inhibitors comes from actual fat, not just water. Research shows reductions in both visceral fat (the deep fat around your organs) and subcutaneous fat (the fat under your skin). This is an important distinction from diuretics, which only cause temporary water weight loss that returns as soon as your body rehydrates.
These medications were originally developed for type 2 diabetes, so they’re most commonly prescribed to people who have both diabetes and high blood pressure. If you don’t have diabetes, your doctor may still consider them for their cardiovascular benefits, but this would be off-label use. Common side effects include urinary tract infections and genital yeast infections, a direct consequence of the extra sugar passing through the urinary tract.
GLP-1 Receptor Agonists: The Biggest Weight Loss
GLP-1 receptor agonists produce the most dramatic weight loss of any medication that also affects blood pressure. These drugs mimic a gut hormone that slows digestion, reduces appetite, and helps regulate blood sugar. They also lower systolic blood pressure, though they’re not classified as blood pressure medications and wouldn’t typically be prescribed for hypertension alone.
The weight loss numbers are striking. Semaglutide produced 14.9% body weight loss at 68 weeks in the landmark STEP-1 trial. Tirzepatide, a newer dual-action version, achieved 20.9% weight loss at 72 weeks at its highest dose. Even the older drug liraglutide helped a third of patients lose 10% of their body weight. For someone weighing 220 pounds, a 15% loss translates to about 33 pounds.
The catch is that these medications come with frequent digestive side effects: nausea, diarrhea, vomiting, and stomach cramps. These tend to be worst in the first few weeks and improve as your body adjusts. The drugs are given as weekly or daily injections (though oral versions are becoming available), and they’re primarily approved for weight management or diabetes rather than hypertension. If you have high blood pressure and are significantly overweight, they can address both problems at once, but they’re typically added alongside a dedicated blood pressure medication rather than replacing one.
Telmisartan: A Blood Pressure Drug With Metabolic Benefits
Among traditional blood pressure medications, telmisartan stands out. It belongs to the ARB class (angiotensin receptor blockers), which are first-line treatments for hypertension. But unlike other ARBs such as losartan or candesartan, telmisartan activates specific fat-burning pathways in your body that other drugs in its class don’t touch.
Animal studies show telmisartan reduces visceral fat and prevents weight gain on a high-fat diet, and it does this without affecting food intake. The mechanism involves activating pathways that increase fat breakdown and energy expenditure in both fat tissue and skeletal muscle. Research found that telmisartan boosted the activity of these metabolic pathways by roughly 100%, while other ARBs like candesartan and losartan had no effect at all.
The weight loss from telmisartan is more modest than what you’d see with SGLT2 inhibitors or GLP-1 drugs. But if you need an ARB for blood pressure control anyway, choosing telmisartan over another ARB gives you a potential metabolic advantage at no extra cost or risk.
Which Blood Pressure Drugs Are Weight-Neutral
ACE inhibitors (like lisinopril and enalapril) and ARBs as a class don’t cause weight gain or weight loss. Long-term studies in older adults found no change in body composition over three to six years of use. Current guidelines from the American Heart Association list ACE inhibitors, ARBs, calcium channel blockers, and thiazide diuretics as first-line blood pressure treatments. None of these typically cause meaningful weight gain.
Thiazide diuretics deserve a quick note. You might see the scale drop early on, but this is water weight, not fat loss. Your body adjusts, and the number stabilizes. Diuretics don’t burn calories or reduce fat tissue, so any initial weight change is temporary and cosmetic.
Blood Pressure Drugs That Cause Weight Gain
Older beta-blockers are the main culprits. Atenolol and metoprolol are the most commonly associated with weight gain, averaging about 2.6 pounds over six months or more. This happens partly because beta-blockers slow your metabolism and can reduce your energy for physical activity. Newer beta-blockers like carvedilol and nebivolol don’t typically cause weight gain.
Current guidelines no longer recommend beta-blockers as a first-line blood pressure treatment unless you have a specific reason to take one, such as heart failure, a recent heart attack, or a heart rhythm issue. If you’re on an older beta-blocker and struggling with weight, it’s worth asking whether switching to a newer one or a different drug class makes sense for your situation.
Choosing the Right Medication
Your options depend on your full medical picture. If you have type 2 diabetes and hypertension, an SGLT2 inhibitor is a natural choice since it addresses blood sugar, blood pressure, and weight simultaneously. If you’re significantly overweight with or without diabetes, a GLP-1 receptor agonist offers the most weight loss but will likely be prescribed alongside a separate blood pressure drug. If you simply need a standard blood pressure medication and want to avoid weight gain, telmisartan is a smart pick within the ARB class, and ACE inhibitors remain reliably weight-neutral.
No blood pressure medication alone will produce large-scale weight loss. Even the most weight-favorable options work best when combined with dietary changes and physical activity. But choosing medications that work with your metabolism rather than against it can make a real difference over months and years, especially when the alternative is a drug that adds pounds you’re trying to lose.